| 59.32 Delayed Data As of May 22 |  -1.17 / -1.93%Today’s Change | 34.75 Today|||52-Week Range 86.75 | +52.53% Year-to-Date |
| ??Nevro Names D. Keith Grossman Chairman of the Board; Michael DeMane as Lead Director May 20 / PR NewswirePRN - Paid Partner Content | Nevro Corp (NVRO) Q1 2019 Earnings Call Transcript May 10 / MotleyFool.com - Paid Partner Content |
| Nevro (NVRO) Q1 Loss Wider Than Expected, Revenues Down Y/Y May 13 / Zacks.com - Paid Partner Content | Nevro (NVRO) Reports Q1 Loss, Misses Revenue Estimates May 09 / Zacks.com - Paid Partner Content |
| Previous close | 60.49 |
| Today’s open | 60.15 |
| Day’s range | 59.02 - 60.70 |
| Volume | 351,715 |
| Average volume (3 months) | 680,923 |
| Market cap | $1.9B |
| Earnings growth (last year) | -30.98% |
| Earnings growth (this year) | -135.65% |
| Earnings growth (next 5 years) | +13.00% |
| Revenue growth (last year) | +18.56% |
| P/E ratio | NM |
| Price/Sales | 3.02 |
| Price/Book | 7.67 |
| Today’s change | Today’s % change | |
|---|---|---|
| IRTCIrhythm Technologies... | -1.96 | -2.80% |
| INSPInspire Medical Syst... | -0.15 | -0.27% |
| AXGNAxoGen Inc | -0.07 | -0.32% |
| VRAYViewray Inc | -0.08 | -0.92% |
| Next reporting date | August 12, 2019 |
| EPS forecast (this quarter) | -$0.94 |
| Annual revenue (last year) | $387.3M |
| Annual profit (last year) | -$49.2M |
| Net profit margin | -12.70% |
Sector Health Technology |
Industry Medical Specialties |
Chairman, President & Chief Executive Officer D. Keith Grossman |
Vice President- Operations Patrick Schmitz |
Corporate headquarters Redwood City, California |
